# FDA Inspection 1202157 - Rentschler Biopharma SE - March 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/300ac9e9-db9e-4c2e-a99e-94a03668b9ed
Source feed: FDA_Inspections

> FDA Inspection 1202157 for Rentschler Biopharma SE on March 07, 2023. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202157
- Company Name: Rentschler Biopharma SE
- Inspection Date: 2023-03-07
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1246782 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/0d912736-9230-4aef-96a6-874067c47f8c)
- [FDA Inspection 1160831 - 2021-02-26](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/5c3bee2b-f543-44ea-878b-b0b820cae70f)
- [FDA Inspection 1102650 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/41551671-1c8f-41a7-8269-faa6cb1760fb)
- [FDA Inspection 999800 - 2016-12-06](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/fd3c2655-b57f-4166-9399-c3a17930da99)
- [FDA Inspection 933400 - 2015-06-16](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/72b19de5-5f32-4b03-9fbb-09b85a00b404)

Company: https://www.keypedia.com/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8